Connor, Clark & Lunn Investment Management (CC&L)’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-68,034
| Closed | -$182K | – | 1149 |
|
|
2019
Q2 | $182K | Sell |
68,034
-40,695
| -37% | -$109K | ﹤0.01% | 912 |
|
|
2019
Q1 | $322K | Sell |
108,729
-47,125
| -30% | -$140K | ﹤0.01% | 735 |
|
|
2018
Q4 | $248K | Buy |
155,854
+33,097
| +27% | +$52.7K | ﹤0.01% | 817 |
|
|
2018
Q3 | $452K | Buy |
122,757
+20,450
| +20% | +$75.3K | ﹤0.01% | 718 |
|
|
2018
Q2 | $290K | Buy |
102,307
+3,115
| +3% | +$8.83K | ﹤0.01% | 887 |
|
|
2018
Q1 | $368K | Buy |
99,192
+2,700
| +3% | +$10K | ﹤0.01% | 604 |
|
|
2017
Q4 | $278K | Sell |
96,492
-83,982
| -47% | -$242K | ﹤0.01% | 691 |
|
|
2017
Q3 | $810K | Sell |
180,474
-162,075
| -47% | -$727K | ﹤0.01% | 563 |
|
|
2017
Q2 | $1.57M | Buy |
342,549
+32,300
| +10% | +$148K | 0.01% | 426 |
|
|
2017
Q1 | $1.31M | Sell |
310,249
-50,600
| -14% | -$213K | 0.01% | 457 |
|
|
2016
Q4 | $1.49M | Sell |
360,849
-206,658
| -36% | -$853K | 0.01% | 416 |
|
|
2016
Q3 | $4.6M | Sell |
567,507
-276,440
| -33% | -$2.24M | 0.03% | 258 |
|
|
2016
Q2 | $6.58M | Sell |
843,947
-242,500
| -22% | -$1.89M | 0.05% | 211 |
|
|
2016
Q1 | $8.39M | Sell |
1,086,447
-184,600
| -15% | -$1.43M | 0.07% | 174 |
|
|
2015
Q4 | $13.7M | Buy |
1,271,047
+306,900
| +32% | +$3.31M | 0.11% | 112 |
|
|
2015
Q3 | $6.66M | Buy |
964,147
+458,725
| +91% | +$3.17M | 0.05% | 169 |
|
|
2015
Q2 | $4.48M | Buy |
505,422
+88,150
| +21% | +$781K | 0.04% | 165 |
|
|
2015
Q1 | $4.11M | Buy |
417,272
+158,100
| +61% | +$1.56M | 0.03% | 173 |
|
|
2014
Q4 | $3.18M | Buy |
259,172
+185,072
| +250% | +$2.27M | 0.03% | 185 |
|
|
2014
Q3 | $740K | Buy |
74,100
+500
| +0.7% | +$4.99K | 0.01% | 343 |
|
|
2014
Q2 | $593K | Buy |
+73,600
| New | +$593K | ﹤0.01% | 373 |
|